ArticleJournal of clinical medicine2022

Model Informed Precision Dosing Tool Forecasts Trough Infliximab and Associates with Disease Status and Tumor Necrosis Factor-Alpha Levels of Inflammatory Bowel Diseases.

Christian Primas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.